|
Re: so what happens if dm fumbles the ball??
|
5
|
Resverlogix Corp.
|
Jul 12, 2020 08:53AM
|
|
Re: Resverlogix H2 2018 events
|
5
|
Resverlogix Corp.
|
Sep 29, 2018 05:18PM
|
|
Re: Placebo rate for 2 sub groups
|
5
|
Resverlogix Corp.
|
Mar 12, 2019 09:59AM
|
|
Re: Sneaking Suspicion...
|
5
|
Resverlogix Corp.
|
Feb 05, 2021 11:59AM
|
|
Clinical Steering Committee meeting for BETonMACE?
|
5
|
Resverlogix Corp.
|
Aug 24, 2018 09:54AM
|
|
Re: What are we expecting to learn from scheduled webcast ? ( first week of March)
|
5
|
Resverlogix Corp.
|
Feb 23, 2016 11:58AM
|
|
Re: Why I think it's a homerun
|
5
|
Resverlogix Corp.
|
Mar 04, 2019 08:54AM
|
|
Re: Fierce Biotech BET inhibitor/PD-L1 cancer article
|
5
|
Zenith Epigenetics
|
Sep 16, 2016 10:27AM
|
|
Re: Resverlogix Receives Approval Pathway from the FDA as to the Inclusion of USA Patients in the Phase 3 BETonMACE Trial
|
5
|
Resverlogix Corp.
|
Aug 23, 2017 04:57PM
|
|
Re: Monday!
|
5
|
Resverlogix Corp.
|
Sep 26, 2019 09:31PM
|
|
Re: New Trial: Continuation Protocol for ZEN003694 in mCRPC Patients
|
5
|
Zenith Epigenetics
|
Oct 30, 2019 09:11PM
|
|
Re: ... events section now updated... Where's the $$$ coming from
|
5
|
Resverlogix Corp.
|
Apr 02, 2017 10:55PM
|
|
VCAM-1, Neuroinflammation and Neurodegeneration
|
5
|
Resverlogix Corp.
|
May 17, 2019 10:24AM
|
|
Re: Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
5
|
Resverlogix Corp.
|
Jun 06, 2017 12:53PM
|
|
Compounds and Autoimmune
|
5
|
Resverlogix Corp.
|
Jun 21, 2016 12:12PM
|
|
And we wait.......
|
5
|
Resverlogix Corp.
|
Jan 23, 2018 11:05AM
|
|
Re: Pfizer vs J&J - Nonmetastatic prostate cancer
|
5
|
Zenith Epigenetics
|
Feb 06, 2018 11:48AM
|
|
Re: The CKD opportunity
|
5
|
Resverlogix Corp.
|
Jul 27, 2017 11:16AM
|
|
Re: Question to ask at the AGM
|
5
|
Resverlogix Corp.
|
Oct 30, 2019 09:36PM
|
|
Re: New patent application - USA Inventor
|
5
|
Resverlogix Corp.
|
May 09, 2017 07:02AM
|
